C07K 14/515
Angiogenesic factors
Official title: Angiogenesic factors; Angiogenin
C07K14/515 (Angiogenesic factors) appears on 287 US grants and 416 published applications in this corpus.
Search patents in C07K- Granted patents
- 287
- Published applications
- 416
- Assignees
- 198
- Inventors
- 726
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 5 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 7 | 0 |
| 2001 | 3 | 0 |
| 2002 | 11 | 6 |
| 2003 | 8 | 33 |
| 2004 | 4 | 14 |
| 2005 | 3 | 18 |
| 2006 | 8 | 11 |
| 2007 | 6 | 16 |
| 2008 | 5 | 13 |
| 2009 | 7 | 13 |
| 2010 | 14 | 13 |
| 2011 | 8 | 19 |
| 2012 | 8 | 17 |
| 2013 | 15 | 23 |
| 2014 | 14 | 46 |
| 2015 | 27 | 29 |
| 2016 | 20 | 24 |
| 2017 | 14 | 14 |
| 2018 | 11 | 18 |
| 2019 | 14 | 16 |
| 2020 | 15 | 15 |
| 2021 | 6 | 10 |
| 2022 | 8 | 12 |
| 2023 | 8 | 12 |
| 2024 | 7 | 13 |
| 2025 | 0 | 9 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Angiopoietin 2, VEGF dual antagonists25 Aug 2026US 12,715,912 B2AskGene Pharma Inc.
- Carrier protein for improving properties of bioactive protein3 Mar 2026US 12,565,516 B2Zhejiang Doer Biologics Corporation
- Targeted extracellular vesicles for delivery of therapeutics31 Dec 2024US 12,180,481 B2Mercury Bio, Inc.
- Base editing of ANGPTL3 and methods of using same for treatment of disease15 Oct 2024US 12,115,230 B2Verve Therapeutics, Inc.
- Anti-angiogenesis fusion protein and uses thereof6 Aug 2024US 12,054,561 B2Trican Biotechnology Co., Ltd
- Sirna inhibiting expression of amyloid precursor protein (app) gene, drug, and use16 Jul 2026US 2026/0201383 A1BeBetter Med Inc.
- In vivo production of proteins25 Jun 2026US 2026/0174909 A1ModernaTX, Inc.
- Sirna for inhibiting angptl3 gene expression and use thereof30 Oct 2025US 2025/0333730 A1Shanghai Junshi Biosciences Co., Ltd.
- Truncated and fusion proteins14 Aug 2025US 2025/0257332 A1Monash University
- Protein-based advanced wound healing system24 Jul 2025US 2025/0235516 A1University of South Florida
Most cited
By later US patents
- Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins198US 9,303,079 B2Moderna Therapeutics, Inc. · 2016
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating protein deficiency194US 9,061,059 B2Moderna Therapeutics, Inc. · 2015
- CDNA and genes for human angiogenin (angiogenesis factor) and methods of expression132US 4,966,849 APresident and Fellows of Harvard College · 1990
- Modified polynucleotides encoding basic helix-loop-helix family member E41125US 9,107,886 B2Moderna Therapeutics, Inc. · 2015